The study, published today (27 Feb) in the peer-reviewed journal ecancermedicalscience, examined the use of Electron Intraoperative Therapy (ELIOT), which shortens the radiotherapy course from six weeks to one single session during surgery.
The conventional treatment for early breast cancer is breast conserving surgery (BCS) followed by a 5-7 week course of radiotherapy. However many women still undergo mastectomy because they do not have easy access to postoperative radiotherapy centres.
As 85% of local relapses after BCS occur near the initial site of disease there has been an increased interest in using partial breast irradiation (PBI) directed to the tissue immediately surrounding the site of tumour removal.
Investigators have evaluated the use of ELIOT alone for early-stage breast cancer since 1999. This technique uses radiotherapy machines kept or easily moved in the operating theatre. After removal of the tumour, a high accuracy, high dose radiation pulse is delivered to the breast tissue surrounding the site.
Since it was first piloted by the IEO in 1999, ELIOT has been given to 1246 patients, with an overall survival rate at five years of 96.5%. Only 24 out of the 1246 cases (1.9%) saw a breast-cancer related event after this period.
Apart from this success, the system has several other advantages: Cosmetic damage is greatly limited and post-op plastic surgery is easily conducted.
The flexible nature of the radiotherapy machine and its presence during surgery means that additional doses of radiotherapy can be given if needed for specific reasons.
Furthermore, the complete protection against radiation provided by the combination of pin-point doses and protective metal disk means that side effects from unwanted radiation are abolished.
The main advantage, however, is for those patients living in areas remote from radiotherapy centres, who would otherwise have to travel everyday for six weeks, and often decide on complete breast removal to avoid the huge stress of such an undertaking.The investigators state that their results “confirmed the positive impact of ELIOT on patient quality of life: ELIOT is feasible and well accepted. We are waiting for the long-term results on local control from the ongoing randomised trial in progress at our institute to decide whether to adopt the technique in daily standard practice. However, as the data from the present large series are reassuring (97% of local control and 98.8% survival at 5 years) we believe that, at least for women living far from radiotherapy centres and with minimal risk of local recurrence (age > 50 and primary carcinoma
Professor Gordon McVie, of the IEO, added “this is the largest experience in the world of sequential patients treated in a phase II trial with intra-operative radiotherapy. Its unprecedented size and positive results gives great hope for both this technique and breast cancer patients worldwide”.
Linda Cairns | alfa
A 15-minute scan could help diagnose brain damage in newborns
15.11.2018 | Imperial College London
NIH scientists combine technologies to view the retina in unprecedented detail
14.11.2018 | NIH/National Eye Institute
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
16.11.2018 | Health and Medicine
16.11.2018 | Life Sciences
16.11.2018 | Life Sciences